Is the SIBO Diagnosis Conversation Changing? What a Major New Review Argues
A new critical review questions SIBO breath-test reliability. What the paper actually says, what it doesn't, and what to do with your diagnosis.
Image by congerdesign via Pixabay
Is the SIBO Diagnosis Conversation Changing? What a Major New Review Argues
The short answer: yes, but not in the way the headlines suggest. A new critical review from three of the most cited researchers in this field argues that the breath tests most patients are diagnosed with can't, on their own, drive individual treatment decisions, and that SIBO itself should be reframed as a slice of a broader pattern called "small intestinal dysbiosis" rather than a discrete bacterial count. It isn't saying breath testing is useless. It's saying the test result is one input among several, and that treatment plans built on a single test tend not to hold.
If you have a SIBO diagnosis, this changes the conversation about what to actually do with your test results. It fits the broader SIBO picture, and it lines up with what I've been telling patients in clinic for years.
What the review actually says
Shah, Holtmann, and Gibson are gastroenterology researchers in Australia who have spent careers on small intestinal microbial ecology. Their 2026 critical review in JGH Open works through every layer of the current diagnostic conversation and lands on three claims worth knowing.
First, the so-called gold standard, jejunal aspirate culture, where a scope retrieves fluid from the upper small intestine and sends it to a lab, misses most of the bacteria actually living there. Standard culture grows roughly 1% of the gut's microbial inhabitants. So a "negative" gold-standard test rules out very little.
Second, breath testing (hydrogen and methane after a glucose or lactulose challenge) has false-positive and false-negative rates large enough that the authors question whether breath results should drive individual treatment decisions at all. Part of the problem is anatomical. The test can't reliably tell you whether the gas you're measuring came from the small intestine or the large intestine. If transit time is faster than expected, which is common in people with motility issues, the lactulose substrate reaches the colon early and the bacteria there start fermenting it. That looks like a positive small-intestinal result on the report. It isn't.
Third, the authors propose moving toward a different framing entirely. Small intestinal dysbiosis assessed via mucosa-associated microbiome sampling (a biopsy of the small intestinal lining during endoscopy), combined with molecular sequencing rather than cultured counts. That kind of testing isn't yet routinely available outside research labs. The framing matters more than the immediate clinical change.
What it doesn't say
The review isn't arguing that breath testing should be abandoned, nor that SIBO is fake. What it does say is that the standard tests are diagnostically noisier than the field has generally treated them, and that treatment plans built on a single positive test, without consideration for symptoms, history, motility, anatomy, or response to prior antibiotics, are working with incomplete information.
How this fits with what I see in clinic
This argument isn't new to naturopathic gastroenterology. The 2017 North American Consensus on breath testing standardized the methodology and acknowledged interpretive limits at the time, and the validation work that followed has continued to point out issues with how transit time and substrate choice affect results. The new review is louder about it, and it comes from inside the gastroenterology mainstream rather than from the alternative-medicine periphery.
What I see in practice, and what the migrating motor complex literature supports, is this: many patients with a positive breath test also have a motility problem underneath. The migrating motor complex is the cleaning wave that sweeps the small intestine clear between meals. When it slows down, bacteria that belong in the colon start accumulating in the small intestine, and a course of antibiotics may knock the count down temporarily without fixing the reason it built up.
That is why so many people respond to a first round of rifaximin, feel meaningfully better for a few months, and then watch the symptoms slowly come back. The positive result was accurate. The treatment was reasonable. The driver was upstream.
What this means if you have a SIBO diagnosis
Don't throw out your test results. Do bring them back into a conversation with your provider that includes the rest of the picture. A few specific questions to consider:
- What was the test result, and which substrate was used? Glucose and lactulose breath tests have different sensitivity and specificity. The 2017 consensus and subsequent validation work both confirm this matters for how the result should be interpreted.
- What's the motility story? Slow gastric emptying, IBS-C, post-surgical changes to the small bowel, a history of food poisoning, chronic stress, or hormonal shifts that affect transit all sit in the same room as the bacterial count.
- What happened the last time you treated? A positive response that didn't hold tells you something. So does a negative test result alongside obvious clinical SIBO symptoms.
- What's the rest of the picture? Diet quality, meal spacing, sleep, ileocecal valve function, and structural issues all matter alongside whatever the gas test showed.
The treatment plan that holds is usually the one that addresses the overgrowth and the reason it was able to take hold. That generally means motility support after the antimicrobial round, plus attention to meal timing, stress, and any structural piece the history surfaced.
If you want to walk through this in more depth, including what to ask for, when testing is and isn't worth doing, and how to think about treatment sequencing, I put together a free SIBO Guide that lays it out step by step.
FAQ
Should I stop using breath testing for SIBO?
No. Breath testing still gives useful information, and it remains the least invasive way to get any objective signal about small intestinal bacterial activity. The review's argument is that the result should be interpreted alongside symptoms, history, and motility status rather than treated as a single yes-or-no answer.
Does this mean my SIBO diagnosis was wrong?
Not necessarily. A positive breath test does tell you something. What the review challenges is the idea that the number alone is sufficient to drive treatment without considering the rest of the clinical picture. If you had a clear positive and your symptoms matched, the diagnosis was reasonable. The question is whether the treatment plan addressed the drivers.
Why do my SIBO symptoms keep coming back after antibiotics?
The most common reason is that the antibiotic course reduced the bacterial count without fixing why the bacteria were able to accumulate. Motility problems, especially a sluggish migrating motor complex, are the usual culprit. Stress, hormonal shifts, prior food poisoning, abdominal surgery, and meal spacing all affect that system.
Is the new mucosa-associated microbiome test available now?
Not in routine clinical practice. The biopsy-plus-sequencing approach the review proposes lives in research labs for now. It may move into specialty centers in the coming years. For now, breath testing combined with a thorough clinical workup is still the practical option.
What is small intestinal dysbiosis, and how is it different from SIBO?
SIBO is defined by bacterial count or breath gas pattern. Small intestinal dysbiosis is a broader concept that includes which bacteria are present, where they are positioned along the intestinal lining, and how they are functioning, not only how many of them there are. The review argues that this fuller picture matches the clinical reality better than a single count.
Should I push for a jejunal aspirate?
Almost never. The aspirate is invasive, expensive, misses most of the bacteria actually there, and rarely changes the treatment plan in a way that justifies the procedure.
References
- 1.
- 2.
- 3.
